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Purpose: The aim of this study was to determine whether social deprivation is a risk factor for 
late presentation of patients with proliferative diabetic retinopathy and whether it affects their 
access to urgent laser treatment.
Methods: Using a 2:1 case: control design, 102 patients referred to a UK teaching hospital 
as part of the UK Diabetic Retinopathy National Screening Programme were identified for the 
period between 1 June 2010 to 1 June 2013. Social deprivation was scored using the Index of 
Multiple Deprivation 2010. Additional variables considered included age, duration of disease, 
ethnicity, and HbA
1c
 at time of referral.
Results: The cases comprised 34 patients referred with proliferative (grade R3) retinopathy 
with a control group of 68 patients with lower retinopathy grades; two control patients were 
excluded due to incomplete data. On univariate analysis, R3 retinopathy was associated with 
higher social deprivation (P,0.001, Mann–Whitney U-test), and with higher HbA
1c
 (11.5% 
vs 8.4%; P,0.001, Mann–Whitney U-test). Forward stepwise multivariable analysis showed 
that the association of R3 retinopathy with deprivation was significant even after adjusting for 
HbA
1c
 (P=0.016). On univariate analysis South Asian ethnicity was also identified as being a 
risk factor for presentation with R3 retinopathy, but this was no longer significant when HbA
1c
 
was adjusted for in a forward stepwise logistic regression analysis.
Conclusion: In our cohort social deprivation appears to be associated with late presentation of 
proliferative diabetic retinopathy. Our study supports the need to target these groups to reduce 
preventable blindness and to identify strategies which overcome barriers to care.
Keywords: social deprivation, index of multiple deprivation, diabetes, proliferative diabetic 
retinopathy
Introduction
Diabetic retinopathy is the leading cause of blindness in the UK’s working-age 
population1 and has been estimated to cause “legal” blindness in 1,280 people per year 
in the UK.2 It has been predicted that the number of people with diabetes within England 
will increase from an estimated 3.2 million in 2013 to 4.2 million by 2030.3
Of the various retinopathy grading systems that exist, the one adopted by the 
National Health Service Diabetic Eye Screening Programme within England consists 
of three stages:4–8 R1, R2, and R3. R1 (background) retinopathy consists of microaneu-
rysm formation, retinal hemorrhages and cotton wool spots. The additional presence of 
venous beading, venous reduplication and intraretinal microvascular abnormalities are 
indicative of R2 (pre-proliferative) retinopathy. The classification of R3 (proliferative) 
retinopathy is reserved for advanced disease when there are new vessels present on the 
disc or elsewhere, and may include pre-retinal or vitreous hemorrhages, or pre-retinal 
fibrosis.9 Maculopathy is classified separately.
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In the UK all Type 1 diabetic patients over 12 years of age10 
and all Type 2 diabetic patients from the point of diagnosis11 
are offered annual mydriatic digital fundus photography.12 
Patients identified with R3 retinopathy should be seen by 
an ophthalmologist within 2 weeks.10,11 Patients with R3 
retinopathy should receive laser therapy within 2 weeks of 
an ophthalmologist diagnosing the condition.8 Treatment 
with pan retinal photocoagulation (PRP) in patients with R3 
retinopathy reduces retinal neo-vascularization and decreases 
the rate of vitreous hemorrhage and tractional retinal detach-
ment. This has been reported to reduce severe visual loss at 
2 years by up to 50%.13
The link between social deprivation and health is well 
established for a number of specific conditions such as 
cancers of the cervix, lung14 and prostate,15 hypertension,16 
cardiovascular disease,17 diabetes,18 and for overall morbidity 
and life expectancy.19
Within ophthalmology higher levels of social deprivation 
have been associated with pathology such as acute primary 
angle closure glaucoma,20 advanced presentation of primary 
open angle glaucoma,21 presentation with a lower level of 
visual acuity for cataract surgery,22 and late presentation of 
anisometropic amblyopia.23
Longer duration of disease, poorer glycemic control, 
and blood pressure control have all been shown to be 
associated with diabetic retinopathy.24 The aim of this 
study was to investigate whether social deprivation is as an 
independent risk factor for the development of R3 diabetic 
retinopathy.
Methods
All patients referred by the Diabetic Screening Service to the 
University Hospitals Birmingham National Health System 
Foundation Trust Eye Service are identified and key data 
recorded by a Diabetic Eye Screening Failsafe Coordinator. 
These data include: date of referral, grade of retinopathy by 
screener, grade of retinopathy by consultant, date of hospital 
appointment offered, actual date of hospital appointment, 
numbers of cancellations or non-attendances prior to this 
appointment, whether referral for laser was required, date 
of laser offered, actual date of laser treatment, numbers of 
cancellations or non-attendances prior to this laser treat-
ment. From the period 1 June 2010 to 31 May 2013 as part 
of a service evaluation we identified all consecutive patients 
referred with R3 retinopathy that had been confirmed by an 
ophthalmologist according to national screening criteria.8,9,12 
A control group was identified on a 2:1 ratio comprising 
randomly selected “date-matched” R1-R2 (non-R3) patients 
who were referred to the hospital eye service during the 
same period.
Hospital records were used to establish the age, sex, 
ethnicity, type of diabetes, the date at which the patient 
was diagnosed with diabetes, glycemic control (HbA
1c
), 
and lower super-output area (LSOA; a unit of geographi-
cal area derived from the postcode) for each patient. The 
patient’s LSOA was linked to Index of Multiple Deprivation 
(IMD) 2010 reference data to estimate the level of social 
deprivation.
The IMD is a well validated quantifier of socio-economic 
status comprising measurement of deprivation in the fol-
lowing seven domains: income; employment; health and 
disability; education; crime; barriers to housing and services; 
and living environment. Each LSOA in the country is given 
an individual score for each domain. These domains are 
then combined to ascertain the overall level of deprivation 
within the area with higher scores indicating higher levels 
of deprivation. IMD scores were calculated for all of our 
patients based on their postcodes at time of presentation and 
2010 reference IMD data for the West Midlands region. The 
use of IMD data as a measure of social deprivation is well 
described within the literature. IMD data have successfully 
been used to highlight social deprivation as an independent 
risk factor for a number of primary eye conditions including: 
severe neovascular age-related macular degeneration,25 acute 
primary angle closure glaucoma,20 and presentation with a 
lower level of visual acuity for cataract surgery.22
Results
One hundred and two “new” patients were included in 
this study: 34 consecutive patients presenting with R3 
retinopathy and 68 “date-matched” controls with non-R3 
diabetic retinopathy presenting over the same time period; all 
patients were referred via the diabetic screening service. Two 
non-R3 patients were excluded from the analysis (due to incom-
plete data), resulting in 34 patients with R3 retinopathy and 
66 control patients (Table 1).
Patients presenting with r3 retinopathy 
had higher levels of social deprivation 
than controls
Univariate analysis of our cohort showed that presentation 
with R3 retinopathy requiring laser was associated with sig-
nificantly higher levels of social deprivation than presentation 
with non-R3 retinopathy (P,0.001, Mann–Whitney U-test).
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Univariate analysis of other factors
Median HbA
1c
 was higher (11.5%; 9.8%–13.3% interquartile 
range [IQR]) in patients presenting with R3 retinopathy 
than in controls (8.4%, 7.3%–9.3% IQR; P,0.001, Mann–
Whitney U-test). Medians and IQRs have been used to sum-
marize these data as a number of the datasets in this study 
were skewed.
Ethnicity was associated with R3 retinopathy at presen-
tation (Fisher’s exact test, P=0.014). South Asian ethnicity 
significantly increased the risk of being in the R3 group 
with 44% (n=15) of R3 presentations being South Asian vs 
17% (n=11) in the comparator group; this compared with 
53% (n=18) and 77% (n=51) respectively for White British 
patients; Figure 1. This meant that 58% (n=15) of Asian 
patients presented with R3 retinopathy compared with only 
35% (n=18) of White British patients (Fisher’s exact test, 
P=0.007).
Younger age at referral was associated with R3 
retinopathy at presentation. Patients with R3 retinopathy were 
a median of 57 years of age (48–62 IQR) at presentation and 
control patients were 64 years of age (49–77 IQR) (P=0.023, 
Mann–Whitney U-test).
Using a Fisher’s exact test there was no significant rela-
tionship between sex and R3 retinopathy (32% [n=11] in the 
R3 group and 47% [n=31] in the non-R3 group were female, 
P=0.201) or between type of diabetes and presence of R3 
retinopathy (18% [n=6] in the R3 group and 17% [n=11] 
in the non-R3 group had a diagnosis of Type 1 diabetes, 
P=1.0). Similarly we did not find a significant relationship 
between R3 retinopathy and reported duration of diabetes 
(Mann–Whitney U-test).
Multivariable analysis of iMD score with 
r3 retinopathy
Age and ethnicity were excluded from our multivariable 
analysis because they were not significant when HbA
1c
 was 
adjusted for in a forward stepwise logistic regression analysis 
(age; P=0.903, ethnicity; P=0.109).
Forward stepwise multivariable analysis of R3 retin-
opathy with IMD score and HbA
1c
 showed that the IMD 
score was significant after adjusting for HbA
1c
 (P=0.016) 
(Table 1).
Comparisons made between the patients 
presenting with r3 retinopathy
When considering “all laser” (ie, PRP, macular or com-
bined), there was found to be a significant difference in 
time to laser between the ethnicities (P=0.041). Pairwise 
comparison showed that Asian patients waited a median of 
43 days (21–272 days IQR) and White British patients waited 
a median of only 25 days (14–39 days IQR; P=0.043). When 
looking exclusively at urgent PRP for the R3 group, the time 
to laser was a median (IQR) of 24 days (6–32 days) for Asian 
patients compared to 4 days (0–16 days) for White British 
patients. This difference was in part due to two patients in 
the Asian group who had multiple appointments arranged 
and yet did not attend (DNA), resulting in time to laser of 
567 and 589 days, respectively. If these two “outliers” were 
removed, then the difference in time to surgery between 
Asian patients and White British patients was no longer 
significant (P=0.118).
Within the patients presenting with R3 retinopathy there 
was no significant association between either time to laser 
and IMD score (Spearman’s correlation coefficient 0.226, 
Table 1 Demographics of patients included in this study
Parameter Case Control
Diabetic retinopathy grading r3 r1-r2
number of patients 34 66
Mean (sD) age 57 years (12.3) 64 years (18.1)
sex
Male 23 35
Female 11 31
ethnicity
White British 18 51
asian 15 11
african–Caribbean 1 4
Mean (sD) hba1c 11.5% (2.29) 8.4% (1.79)
Abbreviations: sD, standard deviation; hba1c, glycated hemoglobin.
Figure 1 The percentage of patients in the case or control group from each ethnic 
category.
 $VLDQ :KLWH%ULWLVK









$IULFDQ±&DULEEHDQ
3HU
FHQ
WDJH
5UHWLQRSDWK\DQGHWKQLFLW\
&DVHV
&RQWUROV
(WKQLFLW\
Clinical Ophthalmology 2015:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
350
lane et al
P=0.200), or frequency of DNA/cancellations and IMD score 
(Spearman’s correlation coefficient -0.243, P=0.166). There 
was no significant association of HbA
1c
 and time to laser 
within the R3 patient group. There was no correlation 
between IMD score and age and time to laser, or DNA/
cancellation rates. There was no significant difference in total 
DNA or cancellation between the ethnicities.
Discussion
This study shows that patients presenting with R3 retinopa-
thy have higher than predicted levels of social deprivation 
when compared to controls. This effect is independent of 
HbA
1c
 level.
It has previously been demonstrated that Type 2 diabetes 
is more prevalent in deprived populations26–28 which may, 
in part, explain the increased number of deprived patients 
presenting with R3 retinopathy. It has also been shown that 
patients with higher levels of social deprivation are more 
likely to have worse glycemic control.29,30 This is reflected in 
an increase in mortality18,31 and an increase in micro vascular 
complications.30 In this study we found positive association 
between presence of R3 retinopathy and increased levels of 
HbA
1c
 (11.5% in R3 patients and 8.4% in controls). How-
ever social deprivation was found to be a risk factor for the 
presentation of the R3 retinopathy, even when glycemic 
control was adjusted for.
Previous studies have shown that an increase in social 
deprivation is associated with a decrease in the uptake 
of screening for diabetic retinopathy32–34 although it has 
been suggested that this inequality has reduced since the 
introduction of the national screening program.35 Scanlon 
et al32 showed that the prevalence of diabetes increased with 
deprivation quintile, as did the prevalence of sight threatening 
diabetic retinopathy, whilst the uptake of screening within 
this patient group was reduced. Our findings are consistent 
with this study with the additional finding that the effect of 
socio-economic status is also independent of HbA
1c
.
Our study shows that once patients had been referred from 
screening and attended the hospital eye service there was no 
significant difference in rate of DNA/cancellations or time 
to laser between the socio-economic groups.
ethnicity
The link between diabetes and ethnicity is well established. It is 
believed that 17% of the Asian population living in the UK has 
been diagnosed with Type 2 diabetes compared to 3% of the 
White British population.36 Increased levels of diabetic retinop-
athy in Asian patients were also documented by Raymond et al37 
who found that Asian patients living in the Birmingham and 
Coventry area had an increased risk of sight threatening retin-
opathy when compared with White Europeans.
In this study we have shown that in our local popula-
tion Asian patients have an increased risk of presenting late 
with R3 retinopathy with 44% (n=15) of R3 presentations 
in our cohort being Asian (vs only 17% [n=11] Asians in 
the comparator group). It should be noted that this associa-
tion was no longer present after correction for HbA
1c
 levels, 
suggesting that this is the primary difference between these 
ethnic groups.
In addition to this, Asian patients waited longer for their 
first PRP treatment. This was in part explained by two out-
liers in the Asian group who had multiple DNAs resulting 
in delays to laser of over a year whereas no patients in the 
Caucasian group nor the single African–Caribbean patient 
had any DNA’s prior to attending their first laser treatment. 
This high attendance rate suggests that overall there was 
good engagement regarding the importance of urgent laser. 
Another factor appeared to be that many more laser treat-
ments were performed on the same day as the first clinic 
appointment in the White British group. Since we offer this 
to all patients wherever possible (regardless of ethnicity, IMD 
status or any other demographic factor) this finding would 
suggest that in our community there was greater reluctance 
among the Asian patients to have laser performed on the 
same day as their first clinic appointment.
These ethnic disparities are commonly attributed to gaps 
in patient knowledge. Only 37% of ethnic minority patients 
knew that retinopathy could lead to blindness compared to 
63% of the general population.36 This knowledge gap may be 
associated with language barriers. The 2001 census showed 
that 60% of people from ethnic minority households in the 
UK do not speak English as their main language at home.36 
It is possible that the seriousness of their condition is not well 
conveyed through interpreters (perhaps particularly when 
this is a relative) resulting in non-attendance at retinopathy 
screening appointments.
age
Younger patients were more likely to present to hospital with 
R3 retinopathy. This may represent social factors that result 
in poorer engagement with the screening service or may arise 
from more aggressive disease in the younger age group. It has 
been proposed that young patients produce higher levels of 
vascular endothelial like growth factor38 and so develop R3 
retinopathy at a faster rate than older patients with similar 
diabetic control.
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strengths and limitations of this study
This study suggests that there is a significant association 
between patients presenting with active R3 retinopathy (ie, 
requiring urgent laser therapy) and social deprivation within 
a large multi-ethnic urban UK population.
In this study, we have used a case-control design to com-
pare patients presenting to the community Diabetic Screening 
Service with active R3 retinopathy against “non-R3” patients 
being referred to the hospital eye service on a non-urgent 
basis during the same time period. We recognize that IMD 
reference data are a geographical measure of deprivation, 
rather than an assessment of the individual per se; however 
since it is uncommon for an individual’s circumstances 
to differ widely from the local average the IMD score is 
regarded as a valid tool for assessing socio-economic health 
care inequalities. It is important to recognize that our study 
only included patients who presented to the hospital eye 
service and as such does not include patients who either 
DNA screening, or who failed to attend their first hospital 
outpatient appointment.
It has been suggested that inequalities in health out-
comes between social groups may in part be associated with 
increased smoking levels, poor glycemic control (in diabetic 
patients), raised cholesterol, obesity, lack of education, ease 
of access to services, a reduction in important health checks 
and referral bias.39,40 We recognize that whilst our multi-
variate analysis accounted for glycemic control, we did not 
specifically look at a number of these variables. Further work 
is needed to determine the potential contribution of these 
additional factors to the development of R3 retinopathy in 
patients with high levels of social deprivation.
Further work
Further work is needed to target at risk groups within our 
population cohort, including the socially deprived and minor-
ity ethnic groups. Minority ethnic groups need targeted sup-
port and education to help improve their glycemic control. 
The reluctance among the Asian patients to have laser therapy 
performed on the same day as their first clinic appointment 
needs to be formally investigated using qualitative methods 
since the reasons for this are unknown: possibilities range 
from suspicion or anxiety over the procedure itself to practi-
cal issues such as an inability to stay for the additional length 
of time required.
Conclusion
This study shows that patients with a higher level of 
socio-economic deprivation, who are young, Asian or 
who have poor glycemic control are the most at risk of 
presenting with R3 retinopathy to screening, and thus only 
being referred to the hospital eye service at this advanced 
stage of disease. Measures that might address these issues 
include: targeted education on glycemic control in these 
high-risk groups, improved interpreter services, more 
flexible appointments for younger patients who work dur-
ing the day, and pre-attendance telephone calls to act as 
reminders and to provide opportunities for discussion of 
the patient’s potential concerns. Before prioritizing any of 
these interventions we need greater clarity regarding the 
specific barriers that these patients encounter that result in 
these late presentations of R3 retinopathy, and to this end 
we are planning a qualitative study utilizing interviews 
with these late-presenting patients. It is clear that these 
vulnerable groups need to be prioritized by public health 
policy to help reduce the burden of diabetic eye disease on 
the individual and society.
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